Clinical Trial Update: Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC） [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Utidelone Injection in patients with advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Utidelone Injection (utidelone)

Snippet

Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd. | Conditions: Advanced Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED